Ledger.Open graph →
SEC Form D · Amendment · filed November 13, 2024

DermBiont, Inc

Offering
$45.3M
Sold
$32.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

A. Rich · Boston, MAExec · DirectorDaniel R. Yadegar · Boston, MADirectorSteven R. Basta · Boston, MADirectorKarl R. Beutner · Boston, MAExec · DirectorNichola R. Eliovits · Burlington, MAExec · DirectorMax R. Dawson · Boston, MAExecWilder R. Ramsey · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗